Prognostic Value of Epidermal Growth Factor Receptor Mutations in Resected Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis

Impact of EGFR and KRAS mutations on survival in 1,000 patients with resected lung adenocarcinoma.

(2017) S. P. D'Angelo et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma

(2014) Min Hwan Kim et al.   LUNG CANCER

The Impact of EGFR Mutation Status on Outcomes in Patients With Resected Stage I Non-Small Cell Lung Cancers

(2013) Benjamin Izar et al.   ANNALS OF THORACIC SURGERY

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non–Small-Cell Lung Cancer

(2013) Hai-bo Sun et al.   Clinical Lung Cancer

The Presence of Mutations in Epidermal Growth Factor Receptor Gene Is Not a Prognostic Factor for Long-Term Outcome after Surgical Resection of Non–Small-Cell Lung Cancer

(2013) Young Tae Kim et al.   Journal of Thoracic Oncology

Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas

(2013) Wei-shuai Liu et al.   MEDICAL ONCOLOGY

The mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance

(2013) Taro Ohba et al.   SURGERY TODAY

Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung

(2012) Jin Gu Lee et al.   LUNG CANCER

Non-BAC Component but not Epidermal Growth Factor Receptor Gene Mutation is Associated with Poor Outcomes in Small Adenocarcinoma of the Lung

(2010) Naruyuki Kobayashi et al.   Journal of Thoracic Oncology

Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer

(2010) Youngil Koh et al.   Journal of Thoracic Oncology

Prognostic Implications of Epidermal Growth Factor Receptor and KRAS Gene Mutations and Epidermal Growth Factor Receptor Gene Copy Numbers in Patients with Surgically Resectable Non-small Cell Lung Cancer in Taiwan

(2010) Hui-Ping Liu et al.   Journal of Thoracic Oncology

Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-small Cell Lung Cancer

(2010) Ming-Sound Tsao et al.   Journal of Thoracic Oncology

Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma

(2009) Young Joo Lee et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer

(2009) Shinobu Hosokawa et al.   LUNG CANCER

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients

(2008) M I Galleges Ruiz et al.   BRITISH JOURNAL OF CANCER

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

(2008) Jenifer L. Marks et al.   Journal of Thoracic Oncology

Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer

(2008) Hidefumi Sasaki et al.   LUNG CANCER

Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations

(2008) Kenji Sugio et al.   LUNG CANCER

ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer

(2007) Kyung-Hun Lee et al.   LUNG CANCER